SCHEMBL19365036

CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCNC(=O)CCCC(=O)NC12CNCCNCC(N)(CNCCNC1)CNCCNC2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)C(C)C)C(N)=O

nearest known ligand 0.64

Predicted protein targets (top 4)

	gene	UniProt	supporting neighbours	confidence
▸	GRPR	P30550	14/20	0.57

▸	NMBR	P28336	2/20	0.57

▸	ITGB3	P05106	1/20	0.54

▸	ITGAV	P06756	1/20	0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL21186302	0.99	GRPR (0.56)	GRPRNMBRITGB3ITGAV
SCHEMBL19372498	0.94	GRPR (0.56)	GRPRNMBRITGB3ITGAV
SCHEMBL19372502	0.93	GRPR (0.56)	GRPRNMBRITGB3ITGAV
SCHEMBL18265511	0.92	GRPR (0.56)	GRPRNMBRITGB3ITGAV
SCHEMBL19365164	0.91	GRPR (0.55)	GRPRNMBRITGB3ITGAV
SCHEMBL19102241	0.90	GRPR (0.52)	GRPRNMBR
SCHEMBL30783571	0.89	GRPR (0.65)	GRPRNMBR
Bombesin SCHEMBL29364598	0.89	GRPR (0.66)	GRPRNMBRITGB3ITGAV
SCHEMBL19372503	0.88	GRPR (0.59)	GRPRNMBRITGB3ITGAV
SCHEMBL16360107	0.88	GRPR (0.58)	GRPRNMBRITGB3ITGAV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20170267698-A1	NITROGEN-CONTAINING MACROCYCLIC CONJUGATES AS RADIOPHARMACEUTICALS	Clarity Pharmaceuticals Ltd (AU)	2017-09-21	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20170267698-A1	NITROGEN-CONTAINING MACROCYCLIC CONJUGATES AS RADIOPHARMACEUTICALS	NCL, NUDC, C3AR1	GRPR 57/4885NMBR 8/4885ITGB3 516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.